ACPU
BMY icon

Arrowgrass Capital Partners (US)’s Bristol-Myers Squibb BMY Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-100,000
Closed -$5.07M – 77
2019
Q3 		$5.07M Hold
100,000
– – 0.38% 76
2019
Q2 		$4.54M Sell
100,000
-140,000
-58% -$6.52M 0.11% 200
2019
Q1 		$11.4M Buy
+240,000
New +$12M 0.34% 93
2018
Q1 		– Sell
-148,900
Closed -$9.13M – 184
2017
Q4 		$9.13M Buy
148,900
+147,099
+8,168% +$9.2M 0.09% 237
2017
Q3 		$11.5M Sell
1,801
-993
-36% -$58K 0.08% 258
2017
Q2 		$15.6M Buy
2,794
+790
+39% +$43K 0.12% 224
2017
Q1 		$10.9M Buy
2,004
+1,848
+1,185% +$101K 0.11% 229
2016
Q4 		$912K Buy
156
+88
+129% +$4.81K 0.01% 433
2016
Q3 		$367K Hold
68
– – ﹤0.01% 409
2016
Q2 		$500K Buy
68
+8
+13% +$565 0.01% 376
2016
Q1 		$383K Sell
60
-300
-83% -$18.9K ﹤0.01% 356
2015
Q4 		$2.48M Hold
360
– – 0.03% 226
2015
Q3 		$2.13M Hold
360
– – 0.04% 253
2015
Q2 		$2.4M Buy
360
+63
+21% +$4.15K 0.04% 314
2015
Q1 		$1.92M Sell
297
-983,803
-100% -$61.6M 0.03% 258
2014
Q4 		$58.1M Buy
984,100
+399,300
+68% +$22.5M 1.03% 18
2014
Q3 		$29.9M Buy
+584,800
New +$29.2M 0.73% 26
2013
Q4 		– Sell
-100,000
Closed -$4.63M – 159
2013
Q3 		$4.63M Buy
+100,000
New +$4.39M 0.17% 104

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s BMY Position: Q4 2019 in Review

Arrowgrass Capital Partners (US) sold out of Bristol-Myers Squibb (BMY) in Q4 2019, closing a stake of 21,224 shares — an estimated $1.08M sold.

Arrowgrass Capital Partners (US) first reported a position in BMY in Q4 2014 and held it in 11 quarters. The position peaked at $13.7M in Q4 2014. 2,218 funds tracked by Wall St. Rank hold BMY as of Q4 2019.

  • Arrowgrass Capital Partners (US) reported no remaining Bristol-Myers Squibb position as of Q4 2019 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 21,224 Bristol-Myers Squibb shares in Q4 2019, an estimated $1.08M.
  • Arrowgrass Capital Partners (US) first reported a position in Bristol-Myers Squibb in Q4 2014 and held it in 11 quarters.
  • Arrowgrass Capital Partners (US)'s Bristol-Myers Squibb position peaked at $13.7M in Q4 2014.
  • 2,218 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2019.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q4 2019, filed 14 Feb 2020.